In situ Injection of pH- and Temperature-Sensitive Nanomaterials Increases Chemo-Photothermal Efficacy by Alleviating the Tumor Immunosuppressive Microenvironment
Jianhua Liu,Liantao Guo,Yan Rao,Weijie Zheng,Dongcheng Gao,Jing Zhang,Lan Luo,Xinwen Kuang,Saraswati Sukumar,Yi Tu,Chuang Chen,Shengrong Sun
DOI: https://doi.org/10.2147/IJN.S367121
IF: 7.033
2022-06-16
International Journal of Nanomedicine
Abstract:Jianhua Liu, 1, &ast Liantao Guo, 1, &ast Yan Rao, 2 Weijie Zheng, 1 Dongcheng Gao, 1 Jing Zhang, 2 Lan Luo, 1 Xinwen Kuang, 1 Saraswati Sukumar, 3 Yi Tu, 1 Chuang Chen, 1 Shengrong Sun 1 1 Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan, People's Republic of China; 2 Animal Biosafety Level III Laboratory at the Center for Animal Experiment, Wuhan University School of Medicine, Wuhan, People's Republic of China; 3 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA &astThese authors contributed equally to this work Correspondence: Shengrong Sun; Chuang Chen, Tel +86-13707198696 ; +86-1476064785, Email ; Purpose: Triple-negative breast cancer (TNBC) is challenging to treat with traditional "standard of care" therapy due to the lack of targetable biomarkers and rapid progression to distant metastasis. Methods: We synthesized a novel combination regimen that included chemotherapy and photothermal therapy (PTT) to address this problem. Here, we tested a magnetic nanosystem (MNs-PEG/IR780-DOX micelles) loaded with the near-infrared (NIR) photothermal agent IR780 and doxorubicin (DOX) to achieve chemo-photothermal and boost antitumor immunity. Intraductal (i.duc) administration of MNs-PEG/IR780-DOX could increase the concentration of the drug in the tumor while reducing systemic side effects. Results: We showed more uptake of MNs-PEG/IR780-DOX by 4T1-luc cells and higher penetration in the tumor. MNs-PEG/IR780-DOX exhibited excellent photothermal conversion in vivo and in vitro. The release of DOX from MNs-PEG/IR780-DOX is pH- and temperature-sensitive. Facilitated by i.duc administration, MNs-PEG/IR780-DOX displayed antitumor effects and prevented distant organs metastasis under NIR laser (L) irradiation and magnetic field (MF)while avoiding DOX-induced toxicity. More importantly, MNs-PEG/IR780-DOX alleviated tumor immunosuppressive microenvironment by increasing tumor CD8 + T cells infiltration and reducing the proportion of myeloid-derived suppressor cells (MDSCs) and Tregs. Conclusion: Intraductal administration of pH- and temperature-sensitive MNs-PEG/IR780-DOX with L and MF had the potential for achieving minimally invasive, targeted, and accurate treatment of TNBC. Keywords: triple-negative breast cancer, photothermal therapy, near-infrared image, intraductal administration, tumor immunosuppressive microenvironment Breast cancer ranks first among the most prevalent malignancies globally. 1 Triple-negative breast cancer (TNBC) consists of 12–17% of breast cancer cases. 2,3 Due to the absence or low expression of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), hormone therapy and HER2 inhibitors are ineffective in TNBC, leading to a poor prognosis of TNBC. Chemotherapy, particularly doxorubicin (DOX), remains the primary adjuvant treatment for patients with TNBC. 4 However, several significant issues, such as severe cardiotoxicity and poor tumor penetration, restrict the DOX use. 5,6 Therefore, it is necessary to improve the permeability and retention of drugs in tumors while reducing toxicity. Nanocarrier-based drug delivery systems developed rapidly to improve anti-cancer therapy. 7 Compared with the traditional free drugs, nano carrier-based drug delivery has unique advantages. It can increase preferential tumor accumulation due to passive targeting 8 or active targeting by conjugation of ligands that recognize "receptor" molecules expressed on cancer cells, such as hyaluronic acid (HA), 9 TAT, 10 iRGD, 11 polysorbate 80, 12 and chlorotoxin. 13 Nevertheless, the complexity of nano-delivery system design and the lack of molecules specifically expressed on cancer cells limit their therapeutic effectiveness. 14,15 Thus, it is difficult to eradicate tumors using nano-platform chemotherapy alone. Combined with other therapies, this could break through the limitations of each treatment, resulting in collaborative enhanced super-additive therapeutic outcomes (namely "1 + 1 > 2"). 16,17 Nanoparticle-mediated photothermal therapy (PTT) has been applied as an adjuvant cancer treatment strategy to improve the therapeutic effect of chemotherapy. 18,19 PTT induces protein denaturation and aggregation, physical alteration of chromatin, and inhibition of DNA synthesis and repair. 20 Photothermal destruction-induced tumor cell immunogenic death (ICD) results in the deat -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology